Ajanta Pharma has reported results for third quarter ended December 31, 2016.
The company has reported 64.58% rise in its net profit at Rs 170.98 crore for the quarter under review as compared to Rs 103.89 crore for the same quarter in the previous year. Total income of the company increased by 30.52% at Rs 559.68 crore for the quarter under review as compared to Rs 428.81 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported 25.15% rise in its net profit at Rs 142.60 crore for the quarter ended December 31, 2016, as compared to Rs 113.94 crore for the same quarter in the previous year. Total income of the company increased by 15.31% to Rs 552.30 crore for quarter under review from Rs 478.96 crore for the quarter ended December 31, 2015.
